| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e232e12040516e2a9393d5abb137227c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99362056ffa5577b1035d6dec930d3f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8a3c318e719790daa4b1a82b7baed78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fcce0d2143c46511dd05f51d27bf44cf |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-593
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-593
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
2007-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2629eb6a7dbfb362067655026e0e5eed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21eaf0ed1f498783b2ed75bb7f55b47c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6eb799fa53177d7e4be0108b9b4c5e77 |
| publicationDate |
2008-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008074144-A1 |
| titleOfInvention |
A composition containing a bisphosphonic acid in combination with vitamin d |
| abstract |
The present invention relates to pharmaceutical compositions containing a bisphosphonic acid in combination with a non-activated metabolite of vitamin D for oral administration. The compositions of the invention either do not contain or contain only low concentrations of a glidant. Also provided are methods for preparing such compositions and methods of use thereof, for preventing or treating abnormal bone resorption in mammals. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2210596-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010084111-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010084111-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3332773-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PT-106978-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3650016-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9044401-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11253528-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014193255-A1 |
| priorityDate |
2006-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |